Sepsis Clinical Trials in Philadelphia, Pennsylvania
6 studies are recruiting for sepsis in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
This study will enroll adults aged 18 to 80 years diagnosed with sepsis due to a suspected or confirmed bacterial infection, within 7 days of being admitted to the hospital, and who have also developed acute kidney injury within 72 hours of the onset of sepsis. Eligible participants will be randoml…
- Stage
- Phase 2
- Ages
- 18 to 80
- Site
- Research Site, Philadelphia, Pennsylvania
- Locations
- 74 in total
- Run by
- AstraZeneca
-
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
The goal of this clinical trial is to determine if vancomycin dosing in children with sepsis can be improved by using updated, personalized dosing models that account for new markers of an individual's kidney function. Vancomycin is prescribed based on the known information of how the body breaks t…
- Stage
- Phase 1
- Ages
- 0 to 17
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Run by
- Children's Hospital of Philadelphia
-
Safe and Explainable AI
While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical know…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
- Run by
- Abramson Cancer Center at Penn Medicine
-
The APS Phenotyping Study
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Pennsylvania, Philadelphia, Pennsylvania
- Locations
- 20 in total
- Run by
- Vanderbilt University Medical Center
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
To demonstrate that external drainage of thoracic duct lymph during sepsis results in a reduction in circulating pro-inflammatory cytokines. To demonstrate safety and feasibility of early thoracic duct cannulation and external lymph drainage for up to 7 days in adult surgical intensive care patient…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
- Run by
- University of Pennsylvania
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU). There are two groups of subjects in this study: PICU clinicians/sepsi…
- Stage
- Not phased
- Ages
- Any age
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 4 in total
- Run by
- Children's Hospital of Philadelphia
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.